Vaccine providers permitted to resume J&J vaccinations in Ohio

Local News

The Ohio Department of Health is issuing guidance to providers to ensure they have access to the latest information

FILE – In this March 3, 2021, file photo, Johnson & Johnson COVID-19 vaccine is held by pharmacist Madeline Acquilano at Hartford Hospital in Hartford, Conn. U.S. health officials are weighing next steps as they investigate unusual blood clots in a small number of people given the vaccine — a one-dose shot that many countries hoped would help speed protection against the pandemic. (AP Photo/Jessica Hill, File)

COLUMBUS, Ohio (WKBN) – Following the recommendation from the CDC’s Advisory Committee on Immunization (ACIP) Friday that the use of the Johnson & Johnson vaccine can resume in the U.S., Ohio Governor Mike DeWine has released the following statement:

“Our country’s vaccine safety system has worked as designed – these extremely rare, serious blood-clotting events were reported into the CDC’s Vaccine Adverse Event Reporting System (VAERS), and the vaccine distribution was paused to allow a thorough review of the facts and time to educate healthcare providers on the rare events. Now, a comprehensive analysis by the independent medical professionals on the ACIP has resulted in the recommendation that the benefits of Johnson & Johnson vaccine outweigh the risks, and that vaccine administration resume. The CDC and FDA have accepted those recommendations, lifting the pause on the Johnson & Johnson COVID-19 vaccine. Providers in Ohio are permitted to immediately resume administering Johnson & Johnson vaccines in Ohio, provided they continue to follow all guidance by the CDC and FDA.”

The Ohio Department of Health is issuing guidance to providers to ensure they have access to the latest information on the use of Johnson & Johnson vaccines, and that healthcare providers are aware of treatment methods for these extremely rare but potentially life-threatening cases of thrombosis with thrombocytopenia syndrome (TTS).

According to the FDA, people who have received the Johnson & Johnson COVID-19 vaccine and develop shortness of breath, chest pain, leg swelling, persistent abdominal pain, neurological symptoms (including severe or persistent headaches or blurred vision) or petechiae beyond the site of vaccination should seek immediate medical care.

Additional information on mass vaccination clinics, mobile vaccine strategies and specific sites resuming Johnson & Johnson are not available at this time.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Mel Robbins Main Area Middle

Trending on WYTV.com